Scopus
🔓 Açık Erişim YÖKSİS DOI Eşleşti
SJR Q1
Risks of adverse obstetric outcomes among female survivors of adolescent and young adult cancer in England (TYACSS): a population-based, retrospective cohort study
Lancet Oncology · Ağustos 2024
Özet
Background: There are limited data on the risks of obstetric complications among survivors of adolescent and young adult cancer with most previous studies only reporting risks for all types of cancers combined. The aim of this study was to quantify deficits in birth rates and risks of obstetric complications for female survivors of 17 specific types of adolescent and young adult cancer. Methods: The Teenage and Young Adult Cancer Survivor Study (TYACSS)—a retrospective, population-based cohort of 200 945 5-year survivors of cancer diagnosed at age 15–39 years from England and Wales—was linked to the English Hospital Episode Statistics (HES) database from April 1, 1997, to March 31, 2022. The cohort included 17 different types of adolescent and young adult cancers. We ascertained 27 specific obstetric complications through HES among 96 947 women in the TYACSS cohort. Observed and expected numbers for births and obstetric complications were compared between the study cohort and the general population of England to identify survivors of adolescent and young adult cancer at a heighted risk of birth deficits and obstetric complications relative to the general population. Findings: Between April 1, 1997, and March 31, 2022, 21 437 births were observed among 13 886 female survivors of adolescent and young adult cancer from England, which was lower than expected (observed-to-expected ratio: 0·68, 95% CI 0·67–0·69). Other survivors of genitourinary, cervical, and breast cancer had under 50% of expected births. Focusing on more common (observed ≥100) obstetric complications that were at least moderately in excess (observed-to-expected ratio ≥1·25), survivors of cervical cancer were at risk of malpresentation of fetus, obstructed labour, amniotic fluid and membranes disorders, premature rupture of membranes, preterm birth, placental disorders including placenta praevia, and antepartum haemorrhage. Survivors of leukaemia were at risk of preterm delivery, obstructed labour, postpartum haemorrhage, and retained placenta. Survivors of all other specific cancers had no more than two obstetric complications that exceeded an observed-to-expected ratio of 1·25 or greater. Interpretation: Survivors of cervical cancer and leukaemia are at risk of several serious obstetric complications; therefore, any pregnancy should be considered high-risk and would benefit from obstetrician-led antenatal care. Despite observing deficits in birth rates across all 17 different types of adolescent and young adult cancer, we provide reassurance for almost all survivors of adolescent and young adult cancer concerning their risk of almost all obstetric complications. Our results provide evidence for the development of clinical guidelines relating to counselling and surveillance of obstetrical risk for female survivors of adolescent and young adult cancer. Funding: Children with Cancer UK, The Brain Tumour Charity, and Academy of Medical Sciences.
YÖKSİS Kayıtları
Risks of adverse obstetric outcomes among female survivors of adolescent and young adult cancer in England (TYACSS): a population-based, retrospective cohort study
The Lancet Oncology · 2024 SCI-Expanded
Dr. Öğr. Üyesi CEREN SÜNGÜÇ →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 3 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 3 kaydı bulundu.
Risks of adverse obstetric outcomes among female survivors of adolescent and young adult cancer in England (TYACSS): a population-based, retrospective cohort study
2024 ISSN: 1470-2045 SCI-Expanded Q1
Dr. Öğr. Üyesi CEREN SÜNGÜÇ →
Adverse obstetric outcomes in female survivors of adolescent and young adult cancers – Authors reply
2024 ISSN: 1470-2045 SCI-Expanded
Dr. Öğr. Üyesi CEREN SÜNGÜÇ →
Makale Bilgileri
Dergi
Lancet Oncology
Toplam Atıf
19 atıf
· Scopus
ISSN14702045
Yayın TarihiAğustos 2024
Cilt / Sayfa25 · 1080-1091
Scopus ID2-s2.0-85198282029
Erişim🔓 Açık Erişim
Kurumlar
MRC Centre for Reproductive Health
Edinburgh United Kingdom
National Institute for Health and Care Research
Royston United Kingdom
NHS Lothian
Edinburgh United Kingdom
St. Michael's Hospital
Bristol United Kingdom
University of Birmingham
Birmingham United Kingdom
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 19.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
The Lancet Oncology
Q1
SJR Skoru9,432
H-Index455
YayıncıElsevier Ltd
ÜlkeUnited Kingdom
Oncology (Q1)
Metrikler
19
Atıf